Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ivabradine for Rate Control in Permanent Atrial Fibrillation

NCT03987204 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT03987204
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03987204 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ivabradine for Rate Control in Permanent Atrial Fibrillation
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Completed
Start date
June 15, 2019
Completion date
September 17, 2019
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, atrial fibrillation, persistent